Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 2,083 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the company’s stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $21.00, for a total value of $43,743.00. Following the transaction, the chief accounting officer directly owned 858 shares in the company, valued at approximately $18,018. This trade represents a 70.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Craig Gracey also recently made the following trade(s):

• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total value of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Up 1.3%

Shares of OMDA opened at $21.95 on Wednesday. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The business’s fifty day moving average is $16.83 and its 200 day moving average is $14.93. The stock has a market cap of $1.30 billion and a P/E ratio of -81.30.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The business had revenue of $78.05 million during the quarter. On average, analysts expect that Omada Health, Inc. will post -0.01 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on OMDA. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research report on Friday, May 8th. Weiss Ratings raised Omada Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday. Citizens Jmp increased their price objective on Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research note on Friday, May 8th. Wells Fargo & Company raised their target price on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Finally, Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday. Ten equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Omada Health has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Institutional Investors Weigh In On Omada Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in OMDA. Raymond James Financial Inc. bought a new position in shares of Omada Health during the 2nd quarter worth approximately $32,000. Quarry LP purchased a new stake in shares of Omada Health during the fourth quarter valued at approximately $29,000. TD Waterhouse Canada Inc. bought a new stake in Omada Health during the fourth quarter worth $32,000. Inlight Wealth Management LLC purchased a new position in Omada Health in the fourth quarter worth $45,000. Finally, JPMorgan Chase & Co. purchased a new position in Omada Health in the third quarter worth $82,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.